ClinicalTrials.gov
ClinicalTrials.gov Menu

1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01162785
Recruitment Status : Completed
First Posted : July 15, 2010
Last Update Posted : November 28, 2016
Sponsor:
Collaborators:
FKD Therapies Oy of Finland
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2016
  Actual Study Completion Date : November 2016